Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132962) titled 'Development, Clinical Application and Translation of AI-Based Gut Microbiota Nutritional Formula for Type 2 Diabetes Mellitus' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Hospital of Hebei Medical University
Condition:
Type 2 Diabetes Mellitus
Intervention:
Intervention group:Based on the original type 2 diabetes treatment plan, a diabetes intestinal microecological nutritional supplement was administered simultaneously for a 12-week intervention
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-10-08
Target Sample Size: ...